Patents
US 12090261 B2: Method for modulating endothelial glycocalyx structure
- Granted
- 2024-09-17
- Filed
- 2021-11-15 application 17526663
- Type
- Utility · 17 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention provides methods and devices for augmenting impaired glycocalyx barrier function in a subject in need thereof by contacting a sample (e.g., blood) obtained from the subject with a glycocalyx-mimetic adsorption media. The adsorption media includes glycosaminoglycan structures and, optionally, proteoglycan core proteins, which are conducive to enhancing and/or restoring the impaired glycocalyx barrier function in a sample. The contacted sample is subsequently separated from the adsorption media, producing a treated sample that can be infused into the subject. Methods and devices for treating a patient suffering from a disease associated with glycocalyx barrier dysfunction are also provided herein.
Source: PVGPATDIS, file of 2026-04-10 (ipg240917.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| EXTHERA MEDICAL CORPORATION 22 patents | US company or organization | Martinez, CA | ExThera Medical Corp Form D issuer FUZZY medium confidence: same name (legal endings aside) and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Robert S. Ward | Martinez, CA | 28 | PVGPATDIS, file of 2026-04-10 | |
| Keith R. McCrea | Martinez, CA | 22 | PVGPATDIS, file of 2026-04-10 | |
| Lakhmir (Mink) Chawla | Martinez, CA | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61M | Devices for introducing media into, or onto, the body ; devices for transducing body media or for taking media from the body ; devices for producing or ending sleep or stupor | A61M1/3679 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/726 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P3/10 | PVGPATDIS, file of 2026-04-10 |
| B01J | Chemical or physical processes, e.g. catalysis or colloid chemistry; their relevant apparatus | B01J20/24 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2022-04-08 | Assignment Assignment of assignor's interest | WARD, ROBERT S. signed 2020-06-09 MCCREA, KEITH R. signed 2020-06-16 CHAWLA, LAKHMIR (MINK) signed 2020-06-15 | EXTHERA MEDICAL CORPORATION MARTINEZ, CA | 59548/749 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.